VILDISHAL M

This brand name is authorized in Nigeria.

Active ingredients

The drug VILDISHAL M contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII I6B4B2U96P - VILDAGLIPTIN
 

Vildagliptin enhances the sensitivity of beta cells to glucose, resulting in improved glucose-dependent insulin secretion by increasing the endogenous levels of these incretin hormones. The administration of vildagliptin results in a rapid and complete inhibition of DPP-4 activity, resulting in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide).

 
Read more about Vildagliptin
2
UNII 786Z46389E - METFORMIN HYDROCHLORIDE
 

Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia.

 
Read more about Metformin

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-100676 Tablet Vildishal M 50/1000 Tablets TAB 1000 mg; 50 mg 3x10Tablets 37 NF-PP-341714 Vildishal M 50/1000 Tablets Vildagliptin and Metformin Hydrochloride Tablets 50mg/1000mg Vildagliptin 50mg, Metformin Hydrochloride BP 1000mg (Hydroxy Propylcellulose BP, Magnesium Stearate BP, Uniquecoat FCNAQ (EXW) IH (Hydroxy Propyl Methyl Cellulose USP, Polyethylene Glycol USP, Purified Talc USP, Titanium Dioxide BP) A4-100676 Drugs Imported Products 3x10Tablets POM 1 7/14/2023 SHALINA HEALTHCARE NIGERIA LIMITED, 19 Fatai Atere Way, Matori, Mushin 18183973 theophilus.adimoha@shalina.com EAST AFRICAN (INDIA) OVERSEAS, Plot No 1, Pharmacity Selaqui, Dehradun - 248011, Uttarakhand, India, India 21/12/2023
A4-100767 Tablet Vildishal M 50/500 Tablets TAB 500 mg; 50 mg 3x10 Tablets 15 NF-PP-400340 Vildishal M 50/500 Tablets Vildagliptin 50mg, Metformin Hydrochloride 500mg Vildagliptin 50mg, Metformin Hydrochloride 500mg (Excipients: Hydroxy Propyl Cellulose BP, Magnesium Stearate BP, Uniquecoat FCNAQ (EXW) HIS (Hydroxy Propyl Methyl Cellulose USP, Poly Ethylene Glycol, Titanium Dioxide BP, Purified Talc USP), Quinoline Yellow Lake HIS, Dichloromethane BP, Isopropyl Alcohol BP, Purified Water BP) A4-100767 Drugs Imported Products 3X10TABLETS POM 1 1/12/2024 SHALINA HEALTHCARE NIGERIA LIMITED, FATAI ATERE WAY, MATORI MUSHIN LAGOS LAGOS 18183973 theophilus.adimoha@shalina.com EAST AFRICAN (INDIA) OVERSEAS, Plot No 1, Pharmacity Selaqui, Dehradun - 248011, Uttarakhand, India, India 28/02/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A10BD08 Metformin and vildagliptin A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BD Combinations of oral blood glucose lowering drugs
Discover more medicines within A10BD08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-100676, A4-100767

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.